Clinical and histological findings associated with autoantibodies detected by RNA immunoprecipitation in inflammatory myopathies

Journal of Neuroimmunology

Volumn 274, Issue 1-2, 2014, Pages 202-208

  Suzuki, Shigeaki ^a   Yonekawa, Takahiro ^b,c   Kuwana, Masataka ^a   Hayashi, Yukiko K ^d   Okazaki, Yuka ^a   Kawaguchi, Yasushi ^e   Suzuki, Norihiro ^a   Nishino, Ichizo ^b,c  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^d TOKYO MEDICAL UNIVERSITY   (Japan)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Autoantibodies; Inflammatory myopathies; Muscle biopsy; Necrotizing myopathy; RNA immunoprecipitation; Signal recognition particle

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; AUTOANTIBODY; CREATINE KINASE; KU ANTIGEN; LA ANTIBODY; PROTEIN ANTIBODY; PROTEIN U1RNP; RNA; RO ANTIBODY; SIGNAL RECOGNITION PARTICLE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CELL INFILTRATION; CLINICAL EXAMINATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; MALE; MUSCLE ATROPHY; MUSCLE NECROSIS; MUSCLE WEAKNESS; MYOSITIS; ONSET AGE; PRIORITY JOURNAL; VERY ELDERLY;

AUTOANTIBODIES; INFLAMMATORY MYOPATHIES; MUSCLE BIOPSY; NECROTIZING MYOPATHY; RNA IMMUNOPRECIPITATION; SIGNAL RECOGNITION PARTICLE;

ADULT; AGED; AUTOANTIBODIES; CHROMATIN IMMUNOPRECIPITATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCULAR ATROPHY; MYELITIS, TRANSVERSE; MYOSITIS; RNA; SIGNAL RECOGNITION PARTICLE;

EID: 84906936786     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2014.07.006     Document Type: Article

References (21)

1. Aggarwal R., Cassidy E., Fertig N., Koontz D.C., Lucas M., Ascherman D.P., Oddis C.V. Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients. Ann. Rheum. Dis. 2014, 73:227-232.
2. Benveniste O., Drouot L., Jouen F., Charuel J.L., Bloch-Queyrat C., Behin A., Amoura Z., Marie I., Guiguet M., Eymard B., Gilbert D., Tron F., Herson S., Musset L., Boyer O. Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy. Arthritis Rheum. 2011, 63:1961-1971.
3. Chinoy H., Fertig N., Oddis C.V., Ollier W.E., Cooper R.G. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann. Rheum. Dis. 2007, 66:1345-1349.
4. Forman M.S., Nakamura M., Mimori T., Gelpi C., Hardin J.A. Detection of antibodies to small nuclear ribonucleoproteins and small cytoplasmic ribonucleoproteins using unlabeled cell extracts. Arthritis Rheum. 1985, 28:1356-1361.
5. Hamaguchi Y., Fujimoto M., Matsushita T., Kaji K., Komura K., Hasegawa M., Kodera M., Muroi E., Fujikawa K., Seishima M., Yamada H., Yamada R., Sato S., Takehara K., Kuwana M. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. PLoS One 2013, 8:e60442.
6. Hengstman G.J., ter Laak H.J., Vree Egberts W.T., Lundberg I.E., Moutsopoulos H.M., Vencovsky J., Doria A., Mosca M., van Venrooij W.J., van Engelen B.G. Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann. Rheum. Dis. 2006, 65:1635-1638.
7. Hilton-Jones D., Miller A., Parton M., Holton J., Sewry C., Hanna M.G. Inclusion body myositis: MRC Centre for Neuromuscular Diseases, IBM workshop, London, 13 June 2008. Neuromuscul. Disord. 2010, 20:142-147.
8. Hoogendijk J.E., Amato A.A., Lecky B.R., Choy E.H., Lundberg I.E., Rose M.R., Vencovsky J., de Visser M., Hughes R.A. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul. Disord. 2004, 14:337-345.
9. Lerner M.R., Steitz J.A. Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc. Natl. Acad. Sci. U. S. A. 1979, 76:5495-5499.
10. Malicdan M.C., Noguchi S., Nishino I. Monitoring autophagy in muscle diseases. Methods Enzymol. 2009, 453:379-396.
11. Miller F.W. New approaches to the assessment and treatment of the idiopathic inflammatory myopathies. Ann. Rheum. Dis. 2012, 71(Suppl. 2):i82-i85.
12. Miller T., Al-Lozi M.T., Lopate G., Pestronk A. Myopathy with antibodies to the signal recognition particle: clinical and pathological features. J. Neurol. Neurosurg. Psychiatry 2002, 73:420-428.
13. Mimori T. Clinical significance of anti-Ku autoantibodies-a serologic marker of overlap syndrome?. Intern. Med. 2002, 41:1096-1098.
14. Mimori T., Imura Y., Nakashima R., Yoshifuji H. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance. Curr. Opin. Rheumatol. 2007, 19:523-529.
15. Pluk H., van Hoeve B.J., van Dooren S.H., Stammen-Vogelzangs J., van der Heijden A., Schelhaas H.J., Verbeek M.M., Badrising U.A., Arnardottri S., Gheorghe K., Lundberg I.E., Boelens W.C., van Engelen B.G., Pruijn G.J.M. Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis. Ann. Neurol. 2013, 73:397-407.
16. Suzuki S., Ohta M., Shimizu Y., Hayashi Y.K., Nishino I. Anti-signal recognition particle myopathy in the first decade of life. Pediatr. Neurol. 2011, 45:114-116.
17. Suzuki S., Hayashi Y.K., Kuwana M., Tsuburaya R., Suzuki N., Nishino I. Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome. Arch. Neurol. 2012, 69:728-732.
18. Tagawa K., Ogawa M., Kawabe K., Yamanaka G., Matsumura T., Goto K., Nonaka I., Nishino I., Hayashi Y.K. Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients. J. Neurol. Sci. 2003, 211:23-28.
19. Targoff I.N. Autoantibodies in polymyositis. Rheum. Dis. Clin. N. Am. 1992, 18:455-482.
20. Targoff I.N., Johnson A.E., Miller F.W. Antibody to signal recognition particle in polymyositis. Arthritis Rheum. 1990, 33:1361-1370.
21. Valiyil R., Casciola-Rosen L., Hong G., Mammen A., Christopher-Stine L. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series. Arthritis Care Res. 2010, 62:1328-1334.